Delivery Order SPE2DB20D3103-SPE2DB25FP3C7
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,363.27, is for the delivery of Telmisartan 80 mg tablets to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 80 mg tablets. The contract has a firm fixed price and does not utilize any set-aside designation, indicating open competition. The total ceiling value of the contract is $1,537.50, with a period of performance through July 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of telmisartan 80 mg tablets. The contract has a ceiling value of $1,757.97 and a completion date of December 10, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,561,153,990 units of Telmisartan 80 mg tablets in 30-count packages, with a ceiling value of $1,677.74 and a period of performance ending on June 7, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg Tablets, a cardiovascular medication, with a ceiling value of $2,384.82 and a period of performance through January 31, 2023. The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,019.82, is for the delivery of Telmisartan 80 mg tablets to support federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 80 mg tablets. The contract has a firm fixed price of $3,643.06 and a completion date of May 30, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,845.14 to Amerisourcebergen Drug Corp's Corporate Office Division on June 7, 2024. The contract is for the supply of Telmisartan 80 mg tablets in 30-count packages, with a completion date of June 10, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,144.44, is for the supply of telmisartan 80 mg tablets in 30-count packages. The contract is a firm fixed-price delivery order with a period of performance through March 27, 2025. The contract is not designated as a set-aside and was awarded under an Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Telmisartan 80 mg tablets, with a ceiling value of $1,763.27 and a final completion date of June 9, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP3C7Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, with a ceiling value of $4,046.89 and a completion date of June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 6/26/25 |